Mangalam Drugs And Organics Ltd (MANGALAM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532637 | NSE: MANGALAM | Pharmaceuticals & Drugs | Small Cap

Mangalam Drugs&Org. Share Price

63.71 -0.06 -0.09%
as on 07-Nov'25 16:59

Mangalam Drugs And Organics Ltd (MANGALAM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 532637 | NSE: MANGALAM | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Mangalam Drugs&Org.

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Mangalam Drugs And Organics stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
100.8 Cr.
52-wk low:
63.2
52-wk high:
130

Is Mangalam Drugs And Organics Ltd an attractive stock to invest in?

1. Is Mangalam Drugs And Organics Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Mangalam Drugs And Organics Ltd is a average quality company.

2. Is Mangalam Drugs And Organics Ltd undervalued or overvalued?

The key valuation ratios of Mangalam Drugs And Organics Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Mangalam Drugs And Organics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Mangalam Drugs And Organics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Mangalam Drugs&Org.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Mangalam Drugs And Organics Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 29.1%30.2%25.4%1.8%10.7%28%18.3%6.7%1.2%8.4%-
Value Creation
Index
1.11.20.8-0.9-0.21.00.3-0.5-0.9-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 295303279228282385451372369318298
Sales YoY Gr.-2.7%-7.8%-18.5%24.1%36.3%17.3%-17.5%-1%-13.7%-
Adj EPS 11.214.512.3-5.15.217.712.40.8-5.74.3-6
YoY Gr.-29.3%-15.4%-141.6%NA240.5%-29.9%-93.5%-811.3%NA-
BVPS (₹) 36.954.265.660.465.782.695.19689.993.985.3
Adj Net
Profit
16.22319.4-8.18.22819.61.3-96.9-9
Cash Flow from Ops. 21.842.824.621.730.627.625.738.112.242.8-
Debt/CF from Ops. 2.71.52.82.91.62.33.127.82.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 0.9%2.4%-11%-13.7%
Adj EPS -10%-3.5%-29.5%NA
BVPS10.9%7.4%-0.4%4.4%
Share Price -10.5% -16% -23.4% -42.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
35.531.220.5-8.18.223.813.90.8-6.14.7-6.7
Op. Profit
Mgn %
12.815.516.84.38.415.110.96.94.711.47.8
Net Profit
Mgn %
5.57.67-3.62.97.34.30.3-2.52.2-3.2
Debt to
Equity
1.10.80.70.70.50.50.50.50.70.6-
Working Cap
Days
130114130162136126131192201229125
Cash Conv.
Cycle
565862834748699570829

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.59

Return on Equity is Poor

Sales growth has been subdued in last 3 years -10.98%

Sales growth is not so good in last 4 quarters at -16.14%

Latest Financials - Mangalam Drugs And Organics Ltd.

Standalone Consolidated
TTM EPS (₹) -6 -6.2
TTM Sales (₹ Cr.) 298 298
BVPS (₹.) 85.3 80.9
Reserves (₹ Cr.) 119 112
P/BV 0.75 0.79
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 63.20 / 130.00
All Time Low / High (₹) 3.43 / 441.50
Market Cap (₹ Cr.) 101
Equity (₹ Cr.) 15.8
Face Value (₹) 10
Industry PE 39.2

Management X-Ray of Mangalam Drugs&Org.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *20.0417.5218.0817.5814.8810.2611.0113.2313.2334.58
* Pledged shares as % of Promoter's holding (%)

Valuation of Mangalam Drugs&Org. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Mangalam Drugs&Org.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales295303279228282385451372369318
Operating Expenses 257257233218259327402347351282
Manufacturing Costs22232927243042455055
Material Costs204196167154195252307250245167
Employee Cost 14192326263037353941
Other Costs 17191412131516161719
Operating Profit 38464710245849261736
Operating Profit Margin (%) 12.7%15.2%16.8%4.3%8.4%15.1%10.9%6.9%4.7%11.3%
Other Income 0010100000
Interest 91012910911131415
Depreciation 45778910111516
Exceptional Items 0000000000
Profit Before Tax 243129-6640282-115
Tax 8992-21281-2-2
Profit After Tax 162220-8828201-97
PAT Margin (%) 5.4%7.4%7.1%-3.5%2.9%7.3%4.4%0.3%-2.5%2.2%
Adjusted EPS (₹)11.214.112.6-5.15.217.712.40.8-5.74.4
Dividend Payout Ratio (%)0%0%4%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 538610496104131151152142149
Share Capital 14161616161616161616
Reserves 3970888088115135136127133
Minority Interest0000000000
Debt52586259465872688881
Long Term Debt1717119472519139
Short Term Debt35415151425147507572
Trade Payables21213832574355958391
Others Liabilities 34252324243251424438
Total Liabilities 160190227211231264328358357359

Fixed Assets

Gross Block98140156165171197224241261280
Accumulated Depreciation4348546270798999113125
Net Fixed Assets 5493102103101118135142147156
CWIP 5000166983
Investments 0200000000
Inventories473760736559117137124139
Trade Receivables30374518405446472839
Cash Equivalents 0101212113
Others Assets 22211915222622214921
Total Assets 160190227211231264328358357359

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 22432522312826381243
PBT 243129-6640282-115
Adjustment 14171816191722242830
Changes in Working Capital -121-17116-20-1612-47
Tax Paid -4-7-60-0-9-90-0-0
Cash Flow From Investing Activity -11-39-16-9-7-31-27-22-18-19
Capex -11-39-16-9-7-31-28-22-18-19
Net Investments 0-0000000-00
Others 0000000000
Cash Flow From Financing Activity -11-3-9-11-2333-176-22
Net Proceeds from Shares 0100000000
Net Proceeds from Borrowing -22-0-6-3-4318-6-5-4
Interest Paid -9-10-12-9-10-9-11-13-14-15
Dividend Paid 00-10000000
Others 2069-0-99-4225-3
Net Cash Flow -00-010-11-1-02

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)38.9132.1120.99-8.058.2723.8313.970.84-6.154.76
ROCE (%)29.1430.1825.351.7610.6628.0118.346.651.238.4
Asset Turnover Ratio1.841.791.481.181.421.561.521.081.030.89
PAT to CFO Conversion(x)1.381.951.25N/A3.8811.338N/A6.14
Working Capital Days
Receivable Days45394944344541463738
Inventory Days63495894815971125129151
Payable Days68396483837258109133190

Mangalam Drugs And Organics Ltd Stock News

Mangalam Drugs And Organics Ltd FAQs

The current trading price of Mangalam Drugs&Org. on 07-Nov-2025 16:59 is ₹63.71.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-Nov-2025 the market cap of Mangalam Drugs&Org. stood at ₹100.8.
The latest P/E ratio of Mangalam Drugs&Org. as of 06-Nov-2025 is 0.00.
The latest P/B ratio of Mangalam Drugs&Org. as of 06-Nov-2025 is 0.75.
The 52-week high of Mangalam Drugs&Org. is ₹130.0 and the 52-week low is ₹63.20.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Mangalam Drugs&Org. is ₹298.3 ( Cr.) .

About Mangalam Drugs And Organics Ltd

Mangalam Drugs & Organics Limited (Mangalam) is a part of the MangalamGroup promoted by Dhoot family in 1972 as Advent Pharma PrivateLimited with a view to set up a plant for manufacture of organic andinorganic chemicals. Mangalam Drugs & Organics commmenced its business in 1977.

The company manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.

The Company has a diversified product range having synergies in operations and substantial economies of scale. It is amongst the top three manufacturers in India in almost all the products that it manufactures.

Today Mangalam Drugs & Organics enjoys a very strong brand name in the domestic market. It has over two decades of experience in the industry with a very wide and satisfied customer base.

The company has a state of art multi-product manufacturing facilitiesat Vapi in Gujarat and Sangamner in Maharashtra for production of bulkdrugs perfumery chemicals inorganic chemicals and disperse dyesintermediaries with a strong in-house Research and Development base.

Product range of the company includes:

Active Pharma Ingredients (API)

  • Anti Malarial
  • Analgesic / Anti Inflammatory
  • Diuretic
  • Anti Hypertensive
  • Anti Convulsant

API Under Development

  • Intermediates
  • Antiurolithic

Prefumery / Specialty Chemicals

  • Phenyl Ethyl Alcohol
  • Phenyl Ethyl Methyl Ether
  • Phenyl Ethyl Acetate

Disperse Dye Intermediates

  • Meta Nitro Aniline (Mna)(99-09-2)
  • Meta Amino Propionilide (MAP)
  • Meta Amino Acetanilide (MAA) (162-28-3)
  • Para Amino Acetanilide (PAA) 122-80-5)
  • Para Amino Propionilide (PAP) (59690-89-0)
  • N-Cyano Ethyl Aniline (1075-76-9)
  • N,N-BIS (2-Hydroxy Ethyl) Meta Chloro Aniline (Mangalam-1) (92-00-2)
  • N,N-BIS (2-Acetoxy Ethyl) Meta Chloro Aniline (Mangalam -1A) (26692-46-6) etc.

Achievements/ recognition:

  • Awarded the ISO 9001:2000 Management System Certificate from DNV for Design Development, Manufacture and supply of Bulk Drugs, and Dyes Intermediates.
  • Received the WHO GMP Certificate for its Bulk Drug manufacturing Plant
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×